CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Confinement and Communication During the COVID-19 PandemicWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (8)

Name (Synonyms) Correlation
drug1176 Generalized Anxiety Disorder-7 (GAD 7) Wiki 1.00
drug495 C3+ Holter Monitor Wiki 1.00
drug2198 Post Traumatic Stress Disorder questionnaire (PTSD-8) Wiki 1.00
drug2064 Patient Health Questionnaire (PHQ-9) Wiki 1.00
drug1042 Experiences in Close Relationship Scale questionnaire (ECR-S) Wiki 1.00
drug1725 Mental Health questionnaire Wiki 1.00
drug370 Background questionnaire Wiki 1.00
drug1397 Impact of COVID-19 questionnaire Wiki 1.00

Correlated MeSH Terms (2)

Name (Synonyms) Correlation
D040921 Stress Disorders, Traumatic NIH 0.19
D001008 Anxiety Disorders NIH 0.15

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 Stress Induced by the COVID-19 Pandemic and Nonconfinement: Study of Anxiety Factors and Potential Effects on Immunity.

The aim of this project is to evaluate the impact of pandemic and nonconfinement related to anxiety and eventual immune diseases with several standardized questionnaires : Implant Stability Quotient (ISQ) , Generalized Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire -9 (PHQ-9), Post Traumatic Stress Disorder-8 (PTSD-8), and Experiences in Close Relationship Scale (ECRS).

NCT04491071 Stress Disorder Diagnostic Test: Generalized Anxiety Disorder-7 (GAD 7) Diagnostic Test: Background questionnaire Diagnostic Test: Impact of COVID-19 questionnaire Diagnostic Test: Confinement and Communication During the COVID-19 Pandemic Diagnostic Test: Mental Health questionnaire Diagnostic Test: Patient Health Questionnaire (PHQ-9) Diagnostic Test: Post Traumatic Stress Disorder questionnaire (PTSD-8) Diagnostic Test: Experiences in Close Relationship Scale questionnaire (ECR-S)
MeSH:Anxiety Disorders Stress Disorders, Traumatic

Primary Outcomes

Description: test that will evaluate persistent and excessive worry about a number of different things. People with Generalized Anxiety Disorder may anticipate disaster and may be overly concerned about money, health, family, work, or other issues. Individuals with Generalized Anxiety Disorder find it difficult to control their worry. Scored between 0-21: Cut offs: 0-4 = None 5-9 = Mild anxiety 10-14 = Moderate anxiety 15-21 = Severe anxiety

Measure: Results of the Generalized Anxiety Disorder (GAD-7)

Time: 5 Minutes

Secondary Outcomes

Description: Welfare effect (mental health positively or negatively affected by COVID-19; why?) Scored between 7-42. These are treated as continuous variables.

Measure: Results of the Mental Health questionnaire

Time: 5 minutes

Description: assess depression during the pandemic Scored between 0-27: Cut offs: 0-4 = None 5-9 = Mild depression 10-14 = Moderate depression 15-19 = Moderately severe depression 20-27 = Severe depression

Measure: Results of the Patient Health Questionnaire (PHQ-9)

Time: 5 minutes

Description: Assessing the trauma of subjects during the pandemic Scored between 7-42. These are treated as continuous variables.

Measure: Results of the Post Traumatic Stress Disorder (PTSD-8)

Time: 5 minutes

Description: Measuring social ties and attachment of subjects Scored between 7-42. These are treated as continuous variables.

Measure: Results of the Experiences in Close Relationship Scale questionnaire (ECR-S)

Time: 5 minutes

No related HPO nodes (Using clinical trials)